Dublin-based healthcare giant Cardinal Health on Friday agreed to pay $44 million to settle multiple lawsuits regarding the distribution of various controlled substances.

Cardinal Health admitted that it failed to report large orders for powerful painkillers like oxycodone in 2011 and 2012. The company hit the $44 million settlement with the U.S. Department of Justice (DoJ).

Kinray LLC., a New York-based subsidiary of Cardinal Health, also agreed to pay $10 million as part of the settlement.

Craig Morford, the company’s chief legal & compliance officer, claimed that the company remained committed to working with public as well as private partners to do their part and find solutions.

Confirming the settlement, Morford said, “These agreements allow us to move forward and continue to focus on working with all participants in addressing the epidemic of prescription drug abuse. Cardinal Health is committed to working with both public and private partners to do our part and find solutions.”

Amid ruthlessly growing opioid epidemic, battling over-prescription of painkillers like oxycodone has become a priority for the U.S. law enforcement. Painkillers like oxycodone contain chemicals found in drugs like opium and heroin. Deaths from opioid abuse have skyrocketed across the nation in recent years.

– Caroline Robinson
NorCal.news

Follow Prescription Advisory

An improved PDMP … with accurate and timely data analysis should be regarded as the cornerstone of our collective efforts to address prescription drug abuse.

Department of Public Health

Effective monitoring systems [PDMPs] will augment clinical judgment, provide evidence of misuse, and facilitate prescription of the most appropriate analgesic for the situation…The Emergency Department is regarded as the nation’s safety net…the last bastion of around-the-clock access to care … Unfortunately, some of the solutions to opioid misuse [limiting ED physicians to 3-day opioid prescriptions] preempts judgments from trained emergency medical providers.

American College of Physicians, Annals of Internal Medicine, 9 April 2013
Rick Bunker

Rick Bunker

Rick Bunker is a co-founder, and the CEO of Prescription Advisory Systems and Technology (P.A.S.T.). In this role, he is responsible for capital formation and corporate development.
Rick Bunker
Prescription Advisory Systems & Technology

Request a PastRx Demo

We will contact you to arrange a demo at your convenience.

You have Successfully Subscribed!

Prescription Advisory Systems & Technology

Contact PastRx

A representive will be in touch to answer any questions or concerns you might have.

Thank you! A Prescription Advisory representative will contact you shortly.

Share This